Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease

Background: Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial receptor exclusively expressed in the central nervous system (CNS). It contributes to abnormal protein aggregation in neurodegenerative disorders, but its role in Parkinson’s disease (PD) is still unclear.Methods: I...

Full description

Bibliographic Details
Main Authors:	Mingshu Mo, Yuting Tang, Lijian Wei, Jiewen Qiu, Guoyou Peng, Yuwan Lin, Miaomiao Zhou, Wei Dai, Zhiling Zhang, Xiang Chen, Hanqun Liu, Liuyan Ding, Panghai Ye, Yijuan Wu, Xiaoqin Zhu, Zhuohua Wu, Wenyuan Guo, Pingyi Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Parkinson’s disease TREM2 (triggering receptor expressed on myeloid cells) biomarker sleep disorder (SD) cerebrospinal fluid (CSF)
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.753210/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2021.753210/full

Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease

Internet

Similar Items